Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
Sales | 13,283,000 | 14,879,000 | 13,771,000 | 13,232,000 | 13,007,000 |
Cost of Goods | 3,300,000 | 3,379,000 | 7,562,000 | 9,269,000 | 3,237,000 |
Gross Profit | 9,983,000 | 11,500,000 | 6,209,000 | 3,963,000 | 9,770,000 |
Operating Expenses | 8,980,000 | 7,398,000 | 11,295,000 | 7,393,000 | 7,576,000 |
Operating Income | 1,003,000 | 4,102,000 | -5,086,000 | -3,430,000 | 2,194,000 |
Other Income | -1,106,000 | -681,000 | 957,000 | 78,000 | 75,000 |
Pre-tax Income | -103,000 | 3,421,000 | -4,129,000 | -3,352,000 | 2,269,000 |
Income Tax | -134,000 | 293,000 | -795,000 | -964,000 | -71,000 |
Net Income Continuous | 31,000 | 3,128,000 | -3,335,000 | -2,388,000 | 2,340,000 |
Net Income Discontinuous | 17,000 | -5,000 | -26,000 | 12,000 | -2,000 |
Minority Interests | 7,000 | 8,000 | 9,000 | 6,000 | 11,000 |
Net Income | $41,000 | $3,115,000 | $-3,369,000 | $-2,382,000 | $2,327,000 |
EPS Basic Total Ops | 0.01 | 0.55 | -0.59 | -0.42 | 0.41 |
EPS Basic Continuous Ops | 0.01 | 0.55 | -0.59 | -0.42 | 0.41 |
EPS Diluted Total Ops | 0.01 | 0.55 | -0.59 | -0.42 | 0.41 |
EPS Diluted Continuous Ops | 0.01 | 0.55 | -0.59 | -0.42 | 0.41 |
EPS Diluted Before Non-Recurring Items | 0.60 | 0.82 | 0.10 | -0.17 | 0.67 |
EBITDA(a) | $2,734,000 | $5,838,000 | $-3,416,000 | $-1,870,000 | $3,767,000 |